9. I have written at much greater length about musical hallucinations (as well as intrusive musical imagery, or “earworms”) in my book Musicophilia.
5
The Illusions of Parkinsonism
James Parkinson, in his famous 1817 Essay on the Shaking Palsy, portrayed the disease that now bears his name as one that affected movement and posture, while leaving the senses and the intellect unimpaired. And in the century and a half that followed, there was virtually no mention of perceptual disorders or hallucinations in patients with Parkinson’s disease. By the late 1980s, though, physicians had begun to realize (and only in response to careful inquiry, for patients are often reluctant to admit it) that perhaps a third or more of those being treated for Parkinson’s experienced hallucinations, as Gilles Fénelon and others reported. By this time, virtually everyone diagnosed with Parkinson’s was medicated with L-dopa or other drugs that enhance the neurotransmitter dopamine in the brain.
My own experience with parkinsonism as a young doctor was predominantly with the patients I described in Awakenings, who did not have ordinary Parkinson’s disease but a much more complex syndrome. They were survivors of the encephalitis lethargica epidemic that followed the First World War, and they had come down, sometimes decades later, with postencephalitic syndromes including not only a very severe form of parkinsonism but often a host of other disorders, especially sleep and arousal disorders. These postencephalitic patients were far more sensitive to the effects of L-dopa than patients with ordinary Parkinson’s disease. Many of them, once they were started on L-dopa, began to have excessively vivid dreams or nightmares; often this would be the first apparent effect of the medication. Several of them became prone to visual illusions or hallucinations, too.
When Leonard L. was started on L-dopa, he began to see faces on the blank screen of his television set, and a picture of an old western town that hung in his room would come to life as he looked at it, with people emerging from its saloons and cowboys galloping through the streets.
Martha N., another postencephalitic patient, would “sew” with hallucinatory needles and thread. “See what a lovely coverlet I have stitched for you today!” she said on one occasion. “See the pretty dragons, the unicorn in his paddock.” She traced their invisible outlines in the air. “Here, take it,” she said, and placed the ghostly thing in my hands.
With Gertie C., the hallucinations (precipitated by the addition of amantadine to her L-dopa) were less benign. Within three hours of receiving the first dose, she became intensely excited and deliriously hallucinated. She would cry out, “Cars bearing down on me, they’re crowding me!” She also saw faces “like masks popping in and out.” Occasionally she would smile rapturously and exclaim, “Look what a beautiful tree, so beautiful,” and tears of pleasure would fill her eyes.
In contrast to these postencephalitic patients, people with ordinary Parkinson’s disease do not usually experience visual hallucinations until they have been on medication for many months or years. By the 1970s, I had several such patients who had started to get hallucinations, which were predominantly (though not exclusively) visual. Sometimes these began as webs and filigrees or other geometrical patterns; other patients experienced complex hallucinations, usually of animals and people, from the start. Such visions might seem quite real (one patient had a nasty fall while chasing a hallucinatory mouse), but the patients soon learned to distinguish them from reality and ignore them. At the time I could find almost nothing in the medical literature about such hallucinations, although it was sometimes said that L-dopa might make patients “psychotic.” But by 1975, more than a quarter of my patients with ordinary Parkinson’s disease, while otherwise doing well on L-dopa and dopamine agonists, had found themselves living with hallucinations.
Ed W., a designer, started to get visual hallucinations after he had been on L-dopa and dopamine agonists for several years. He realized that they were hallucinations and regarded them largely with curiosity and amusement; nevertheless, one of his physicians declared him “psychotic”—an upsetting misdiagnosis.
He often feels himself “on the verge” of hallucination, and he may be pushed over the threshold at night, or if he is tired or bored. When we had lunch one day, he was having all sorts of what he calls “illusions.” My blue pullover, draped over a chair, became a fierce chimerical animal with an elephant-like head, long blue teeth, and a hint of wings. A bowl of noodles on the table became “a human brain” (though this did not affect his appetite for them). He saw “letters, like teletype” on my lips; they formed “words”—words he could not read. They did not coincide with the words I was speaking. He says that such illusions are “made up” on the spot, instantaneously and without conscious volition. He cannot control or stop them, short of closing his eyes. They are sometimes friendly, sometimes frightening. For the most part, he ignores them.
Sometimes he moves from “illusions” to frank hallucinations. One such was a hallucination of his cat, which had gone to the vet for a few days. Ed continued to “see” her at home, several times a day, emerging from the shadows at one end of the room. She would walk across the room, paying no attention to him, and then disappear into the shadows again. Ed realized at once that this was a hallucination, and had no desire to interact with it (though it aroused his curiosity and interest). When the real cat came back, the phantom cat disappeared.1
In addition to such isolated or occasional hallucinations, people with Parkinson’s may develop elaborate and frightening hallucinations, often of a paranoid sort. Such a psychosis took hold of Ed toward the end of 2011. He started to have hallucinations of people who entered his apartment, emerging from “a secret chamber” behind the kitchen. “They invade my privacy,” Ed said. “They occupy my space.… They are very interested in me—they take notes, take photos, rifle through my papers.” Sometimes they had sex—one of the intruders was a very beautiful woman, and sometimes three or four of them would occupy Ed’s bed when he was not using it. These apparitions never appeared if he had real visitors or when he was listening to music or watching a favorite TV show; nor would they follow him when he left his apartment. He often regarded these persecutors as real and might say to his wife, “Take a cup of coffee to the man in my office.” She always knew when he was hallucinating—he would stare fixedly at one point or follow an invisible presence with his eyes. Increasingly, he started to talk with them—or at them, for they never replied.
Ed’s neurologist, on hearing this, advised him to have “a drug holiday,” to stop all his anti-Parkinson’s medications for two or three weeks, but this left Ed so incapacitated he could hardly move or speak. He then planned a gradual reduction of medication, and, two months later, on half his previous dose of L-dopa, Ed’s hallucinations, his fears, and his psychosis have cleared completely.
In 2008, Tom C., an artist, came to my office for a consultation. He had been diagnosed with Parkinson’s disease and put on medication about fifteen years earlier. Two years later, he started to experience “misperceptions,” as he calls them (like the others, he avoids the term “hallucinations”). He is fond of dancing—he finds that this can unfreeze him, releasing him, for a while, from his parkinsonism. His first misperceptions occurred when he was in a nightclub; the skin of the other dancers, even their faces, seemed to be covered with tattoos. At first he thought the tattoos were real, but they started to glow and then to pulse and writhe; at that point he realized they must be hallucinatory. As an artist and a psychologist, he was intrigued by this experience—but frightened, too, that it might be the beginning of uncontrollable hallucinations of all sorts.
Once, while sitting at his desk, he was surprised to see a picture of the Taj Mahal on his computer monitor. As he gazed, the picture became richer in color, three-dimensional, vividly real. He heard a vague chanting, of the sort he thought might be associated with an Indian temple.
Another day, while he was lying on the floor, frozen by his parkinsonism, the reflections on
a fluorescent ceiling lamp started to change into old photographs, mostly in black and white. These seemed to be photographs from earlier days, mostly of family, with some of strangers. “I had nothing else to do” in this immobilized state, he said, so he happily indulged this mild hallucinatory pleasure.
For Ed W. and Tom C., hallucinations usually remain on the “misperception” side, but Agnes R., a seventy-five-year-old lady who has had Parkinson’s disease for twenty years, has had frank visual hallucinations for the last decade. She is, as she says, “an old hand” at hallucinations: “I see a whole array of things, which I enjoy—they are fascinating; they don’t frighten me.” In the clinic waiting room, she had seen “women—five of them—trying on fur coats.” The size, color, solidity, and movement of these women looked perfectly natural; they seemed absolutely real. She knew that they were hallucinations only because they were out of context: no one would be trying on fur coats on a summer day in a doctor’s office. In general, she is able to distinguish her hallucinations from reality, but there have been exceptions: on one occasion, seeing a furry black animal leap onto the dining table, she jumped. At other times, while walking, she has stopped abruptly to avoid bumping into a hallucinatory figure just in front of her.
Agnes most often sees apparitions from the windows of her twenty-second-floor apartment. From here, she has “seen” a skating rink on top of a (real) church, “people in tennis courts” on neighboring rooftops, and men working just outside her window. She does not recognize any of the people she sees, and they continue whatever they are doing without paying any attention to her. She watches these hallucinatory scenes with equanimity and sometimes with enjoyment. (Indeed, I got the impression that they help her pass the time—time which now seems to pass more slowly with her relative immobility and difficulties reading.) Her visions are not like dreams, she said; nor do they resemble fantasies. She has a great love for travel and for Egypt in particular, but she has never had “Egyptian” hallucinations or travel ones.
She sees no patterns to her hallucinations—they may come at any time of day, when she is busy with others or when she is alone. They seem to have nothing to do with current events, with her feelings, thoughts, or moods, or with the time of day she takes her medication. She cannot will them to come, or will them away. They superimpose themselves on what she is looking at and vanish, along with actual visual perception, when she closes her eyes.
Ed W. often describes a persistent feeling of a “presence”—something or someone he never actually sees—on his right. Professor R., while doing very well on L-dopa and other anti-parkinsonian drugs, also has “a companion” (as he calls it), just out of sight on his right. The sense of someone there is so strong that he sometimes wheels round to look, though there is never anyone to be seen. But his chief illusion is the transformation of print, words and sentences, into musical notation. The first time this happened was about two years ago. He was reading a book, turned away for a few seconds, and found, when he returned to the book, that the print had been replaced by music. This has occurred many times since, and may also be induced by staring at a page of print. Occasionally the dark border of his bath mat turns into staves and lines of music. There is always something—letters or lines—that is transformed into music; this may be why he regards these as “illusions,” not hallucinations.
Professor R. is a very good musician; he started to play the piano when he was five and still plays for many hours a day. He is curious about his illusions, and he has done his best to transcribe or play the illusory music. (His best chance of “catching” this phantom music, he has found, is to set up a newspaper on the music stand and play it as soon as the newsprint turns into music.) But the “music” is scarcely playable, because it is always very highly ornamented, with innumerable crescendo and decrescendo markings, while the melody line is three or more octaves above middle C, and so may have half a dozen or more ledger lines above the treble staff.
Seeing music has been described to me by others (see this page). Esther B., a composer and music teacher, wrote to me that, twelve years after being diagnosed with Parkinson’s, she started to have “a rather peculiar visual phenomenon.” She described this in detail:
When I look at a surface—like a wall, or a floor, or a garment someone is wearing, or a curved surface like a tub or sink, or other surfaces too numerous to mention—I see a sort of collage of music scores superimposed upon the surface, especially with my peripheral vision. When I try to focus on any one image, it dims out or disappears elusively. These images of music scores come unbidden and are especially vivid after I’ve been working with any written music. The images always appear more or less horizontal, and if I tilt my head one way or the other, the horizontal images will tilt accordingly.
Howard H., a psychotherapist, began to notice tactile hallucinations soon after being diagnosed with Parkinson’s, as he wrote:
I would feel that the surfaces of various objects were covered by a film of fuzz, like peach fuzz, or the down in a pillow. It could also be described as cotton candy or spider webs. Sometimes the webs and fuzz can get very “lush,” as when I reach down to pick up something that has fallen under my desk and my hand feels as if it has become submerged in a huge pile of this “stuff.” But when I try to scoop up that pile, I see nothing and yet feel that I have a large amount of this “stuff” in my hands.
Is the use of L-dopa wholly responsible for such effects? Can L-dopa be regarded as a hallucinogenic drug? This seems unlikely in view of the fact that it is used in treating other conditions (such as dystonias) without provoking any hallucinations. Is there then something in the parkinsonian brain, or at least in some parkinsonian brains, which may predispose to visual hallucinations?2
Too often, parkinsonism is seen as no more than a movement disorder, but it may also involve a number of other aspects, including sleep disturbances of various sorts. People with Parkinson’s may sleep poorly at night and often have chronic sleep deprivation. Their sleep may be marked by vivid and sometimes bizarre dreams, or nightmares in which they are awake but paralyzed, helpless to combat dream images being superimposed on their waking consciousness. All of these factors additionally predispose to hallucination.
In 1922 the French neurologist Jean Lhermitte described the sudden onset of visual hallucinations in an elderly patient—people in costume, children playing, animals around her (she would sometimes try to touch them). The patient had insomnia at night and drowsiness in the daytime, and her hallucinations tended to come at dusk.
Though this lady had dramatic visual hallucinations, she had no visual impairments and no lesions in the visual cortex. But she had neurological signs suggesting an unusual pattern of damage in parts of the brain stem, the midbrain, and the pons. It was well known at this point that lesions in the visual pathway could cause hallucinations, but it was not clear how damage in the midbrain—not a visual area—could do so. Lhermitte thought such hallucinations might go with a derangement of the sleep-wake cycle, that they were essentially dreams or dream fragments invading daytime consciousness.
Five years later, the Belgian neurologist Ludo van Bogaert reported a somewhat similar case—his patient suddenly started seeing the heads of animals projected on the walls of his house at dusk. There were neurological signs similar to those of Lhermitte’s patient, and van Bogaert also surmised midbrain damage. When his patient died, a year later, an autopsy revealed a large midbrain infarction involving (among other structures) the cerebral peduncles (hence his coinage of the term “peduncular hallucinations”).
In Parkinson’s disease, postencephalitic parkinsonism, and Lewy body disease, there is damage to the brain stem and associated structures, as there is in peduncular hallucinosis—though the damage occurs gradually and not abruptly, as with a stroke. In all of these degenerative diseases, however, there may be hallucinations, as well as sleep, movement, and cognitive disorders. But the hallucinations are markedly different from those of CBS; they are nearly a
lways complex rather than elementary, often multisensory, and more apt to lead to delusions, which CBS alone rarely does. The hallucinations of brain-stem origin seem to be associated with abnormalities in the acetylcholine transmitter system—abnormalities that may be aggravated by giving the patient L-dopa or similar drugs, which heighten the dopamine load on an already fragile and stressed cholinergic system.
People with ordinary Parkinson’s disease may be active and retain their intellectual powers for decades—Thomas Hobbes, the philosopher, for instance, developed “the shaking palsy” around the age of fifty, when he was completing his Leviathan, but remained intellectually intact and creative, though motorically disabled, into his nineties. But it has been increasingly recognized in the last few years that there is a more malignant form of parkinsonism, one accompanied sooner or later by dementia and by visual hallucinations even in the absence of L-dopa. Examination of the brain at autopsy in such patients may show abnormal aggregates of protein (so-called Lewy bodies) inside the nerve cells, mostly in the brain stem and basal ganglia but also in the visual association cortex. The Lewy bodies, it is conjectured, may predispose patients to visual hallucinations even before they are put on L-dopa.
Edna B. seems to have this disease, though the diagnosis of Lewy body disease cannot be made with certainty in life without doing a brain biopsy. Mrs. B. enjoyed excellent health until her mid-sixties, but in 2009 she developed some tremor in the hands, her first symptoms of parkinsonism. By the summer of 2010 her symptoms included some slowing of movement and speech as well as problems with memory and concentration—she would forget words and thoughts, lose the thread of what she was saying and thinking, and, most distressingly of all, she had hallucinations.